Quarterly Statement Of Cash Flows

Riken Vitamin Co., Ltd. - Filing #7253890

Concept As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
9,335,000,000 JPY
11,571,000,000 JPY
Interest and dividends received
890,000,000 JPY
666,000,000 JPY
Interest paid
-113,000,000 JPY
-113,000,000 JPY
Net cash provided by (used in) operating activities
7,892,000,000 JPY
10,451,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,678,000,000 JPY
-2,536,000,000 JPY
Proceeds from sale of property, plant and equipment
346,000,000 JPY
3,000,000 JPY
Purchase of investment securities
-16,000,000 JPY
-17,000,000 JPY
Proceeds from sale of investment securities
4,990,000,000 JPY
2,970,000,000 JPY
Other, net
-2,000,000 JPY
-35,000,000 JPY
Net cash provided by (used in) investing activities
353,000,000 JPY
-554,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
5,000,000,000 JPY
JPY
Repayments of long-term borrowings
-7,138,000,000 JPY
-2,606,000,000 JPY
Purchase of treasury shares
-1,133,000,000 JPY
-6,360,000,000 JPY
Dividends paid
-2,776,000,000 JPY
-2,194,000,000 JPY
Other, net
-10,000,000 JPY
-22,000,000 JPY
Net cash provided by (used in) financing activities
-9,965,000,000 JPY
-7,084,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
413,000,000 JPY
672,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,306,000,000 JPY
3,485,000,000 JPY
Cash and cash equivalents
18,835,000,000 JPY
20,141,000,000 JPY
16,656,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.